BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 1998
View Archived Issues
AE-0047: a calcium channel blocker with multiple indications
Read More
Company Profile: Aquila Biopharmaceuticals
Read More
IDEC-Y2B8/rituximab combination enters phase III
Read More
Rizatriptan approved in The Netherlands
Read More
AIT-082 enters multidose study
Read More
Noven and Novartis to collaborate on Vivelle
Read More
Antimigraine agents with reduced liability for side effects developed at MS&D
Read More
Orally active thrombin inhibitors prepared at C&C
Read More
Schering AG reports pure antiestrogens
Read More
Beta-lactams with dual beta-lactamase-inhibitory/antibacterial activity from Roche
Read More
Fujisawa develops new inhibitors of NO production
Read More
Medivir studies new anticancer sterols
Read More
Canadian approval obtained for Mirapex
Read More
Taxotere approved in China
Read More
Binding and functional studies with YM-087 in cells expressing human AVP receptors
Read More
Novel 5-HT2A receptor antagonist from medicinal plant: gamma-mangostin
Read More
Beneficial effects of FK-506 in animal model of rheumatoid arthritis
Read More
Preclinical studies support development of G-3139 as chemosensitizer
Read More
Connetics' NDA for betamethasone mousse accepted by FDA
Read More
Development candidate selected by Fujisawa from ACAT inhibitor series
Read More
Milestone reached in Genome Therapeutics/Schering-Plough alliance
Read More
Improved treatment outlook for children with leukemia?
Read More
UroGenesys licenses prostate cancer gene for diagnostic and therapeutic development
Read More
AutoImmune will conduct pivotal study of Colloral
Read More
ProLease formulation of erythropoietin covered by U.S. patent
Read More
Patent coverage for ProLease interferon
Read More
